Company Filing History:
Years Active: 2021
Title: Ae Ri Cho - Innovator in Nucleic Acid Detection
Introduction
Ae Ri Cho is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of molecular biology, particularly in the detection of nucleic acid sequences. His innovative approach has the potential to enhance genetic testing and diagnostics.
Latest Patents
Ae Ri Cho holds a patent for a method for detecting target nucleic acid sequences using a cleaved complementary tag fragment. This invention relates to a method and composition that links a complementary tag sequence to a PCR primer. The tagging is produced by a restriction enzyme during a PCR reaction, allowing for the diversification of the complementary tag sequence linked to each primer. This method improves the accuracy of detecting target sequences by utilizing a cleaved complementary tag fragment (CCTF) that forms only under specific conditions. The CCTF can be employed in various analytical techniques, making it versatile for applications such as genetic testing and diagnosing infections.
Career Highlights
Ae Ri Cho is currently associated with Genematrix Inc., where he continues to work on innovative solutions in the field of genetics. His expertise and contributions have positioned him as a valuable asset in his organization.
Collaborations
He collaborates with talented colleagues, including Soo Ok Kim and Suk Joon Kim, who contribute to the advancement of their projects and research initiatives.
Conclusion
Ae Ri Cho's work in nucleic acid detection exemplifies the impact of innovative thinking in biotechnology. His patent and ongoing research hold promise for improving diagnostic methods and genetic analysis.